Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NanoFlow (NanoFlow BV) is a specialized life sciences instrumentation company that focuses on the real-time characterization of nanoparticles in complex flow environments. The company's core technology, the NanoFlowSizer, utilizes Spatially Resolved Dynamic Light Scattering (SR-DLS) to measure particle size distributions in concentrated and opaque suspensions without the need for sample dilution. This capability is critical for the development and manufacturing of advanced therapeutics, including lipid nanoparticles (LNPs), liposomes, and nano-emulsions. By providing continuous, in-line monitoring, NanoFlow enables pharmaceutical companies to optimize their production processes and ensure product quality in real-time. The company serves a global market, supporting both R&D and large-scale GMP manufacturing applications in the biotech and pharmaceutical sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nano Flow.